Mito-Lonidamine (Mito-LND) is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation (OXPHOS). Mito-Lonidamine inhibits mitochondrial bioenergetics, stimulates the formation of reactive oxygen species, and induces autophagic cell death in lung cancer cells.
Molecular Weight:
801.62
Purity:
98.0%
CAS Number:
[2361564-49-8]
Formula:
C43H45BrCl2N3OP
* VAT and and shipping costs not included. Errors and price changes excepted